Table 1 A comparison of baseline socioeconomic and clinical characteristics of Aboriginal and non-Aboriginal participants
Variable | Aboriginal | Not Aboriginal | P-value |
|---|---|---|---|
(n = 88) | (n = 534) | ||
Year of initiation of therapy, no. (%) | |||
1996 | 8 (9) | 79 (15) | 0.0588 |
1997 | 32 (36) | 225 (42) | |
1998 | 21 (24) | 129 (24) | |
1999 | 27 (31) | 101 (19) | |
Gender, no. (%) | |||
Female | 13 (15) | 49 (9) | 0.1044 |
Male | 75 (85) | 485 (91) | |
Age | |||
Median | 37 | 38 | 0.9669 |
Interquartile range | 33 – 45 | 33 – 44 | |
AIDS diagnosis, no. (%) | |||
Yes | 8 (9) | 99 (19) | 0.0296 |
No | 80 (91) | 435 (81) | |
Protease inhibitor use | |||
Yes | 59 (67) | 418 (78) | 0.0209 |
No | 29 (33) | 116 (22) | |
Baseline CD4 cell count (cells/mm3) | |||
Median | 275 | 260 | 0.6551 |
Interquartile range | 150 – 425 | 110 – 410 | |
Baseline plasma HIV viral load (copies/ml) | |||
Median | 89,350 | 140,000 | < 0.001 |
Interquartile range | 21, 750 – 185,000 | 45,000 – 340, 000 | |
Adherence (<95%), no. (%) | |||
Yes | 58 (66) | 381 (71) | 0.2995 |
No | 30 (34) | 153 (29) | |
HIV physician experience | |||
Median | 29 | 60 | 0.0133 |
Interquartile range | 3 – 116 | 6 – 166 | |
History of IDU, no. (%) | |||
Yes | 52 (59) | 161 (30) | < 0.001 |
No | 36 (41) | 373 (70) | |
Completed high-school, no. (%) | |||
Yes | 38 (43) | 298 (56) | 0.0046 |
No | 43 (49) | 171 (32) | |
Missing | 7 (8) | 65 (12) | |
Income, no. (%) | |||
< $10,000 | 49 (58) | 211 (43) | 0.0115 |
>= $10,000 | 36 (42) | 281 (57) | |
Missing | 3 (3) | 42 (8) |